{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:14:28Z","timestamp":1787933668010,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":353,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","award":["R01-EY017011"],"award-info":[{"award-number":["R01-EY017011"]}],"id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","award":["R01-EY015130"],"award-info":[{"award-number":["R01-EY015130"]}],"id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","award":["6-FY13-75"],"award-info":[{"award-number":["6-FY13-75"]}],"id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-EY017011"],"award-info":[{"award-number":["R01-EY017011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-EY015130"],"award-info":[{"award-number":["R01-EY015130"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["6-FY13-75"],"award-info":[{"award-number":["6-FY13-75"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["R01-EY017011"],"award-info":[{"award-number":["R01-EY017011"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["R01-EY015130"],"award-info":[{"award-number":["R01-EY015130"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["6-FY13-75"],"award-info":[{"award-number":["6-FY13-75"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["R01-EY017011"],"award-info":[{"award-number":["R01-EY017011"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["R01-EY015130"],"award-info":[{"award-number":["R01-EY015130"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","award":["6-FY13-75"],"award-info":[{"award-number":["6-FY13-75"]}],"id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.ajpath.2013.12.023","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T10:01:08Z","timestamp":1394791268000},"page":"1230-1239","source":"Crossref","is-referenced-by-count":59,"title":["VEGFA Activates Erythropoietin Receptor and Enhances VEGFR2-Mediated Pathological Angiogenesis"],"prefix":"10.1016","volume":"184","author":[{"given":"Zhihong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elizabeth","family":"Hartnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.12.023_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajpath.2013.12.023_bib2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.12.023_bib3","first-page":"101","article-title":"Oxygen induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bjo.68.10.689","article-title":"Retrolental fibroplasia now retinopathy of prematurity","volume":"68","author":"Ashton","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib5","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1136\/fetalneonatal-2011-301121","article-title":"Aggressive posterior retinopathy of prematurity in large preterm babies in South India","volume":"97","author":"Shah","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajpath.2013.12.023_bib6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.12.023_bib7","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","article-title":"Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity","volume":"114","author":"Pierce","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajpath.2013.12.023_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1348.062","article-title":"Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases","volume":"1082","author":"Ng","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib10","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.ajpath.2013.12.023_bib11","first-page":"1201","article-title":"The effect of oxygen on vasoformative cell division: evidence that \u2018physiological hypoxia\u2019 is the stimulus for normal retinal vasculogenesis","volume":"36","author":"Chan-Ling","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib12","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995","article-title":"Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia","volume":"15","author":"Stone","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.12.023_bib14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib15","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1167\/iovs.13-11625","article-title":"Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity","volume":"54","author":"McCloskey","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2010.08.001","article-title":"Anaemia of prematurity: pathophysiology and treatment","volume":"24","author":"Strauss","year":"2010","journal-title":"Blood Rev"},{"key":"10.1016\/j.ajpath.2013.12.023_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35088074","article-title":"Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades","volume":"412","author":"Digicaylioglu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2013.12.023_bib18","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1073\/pnas.1031753100","article-title":"Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in\u00a0vivo","volume":"100","author":"Erbayraktar","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.12.023_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1098313","article-title":"Derivatives of erythropoietin that are tissue protective but not erythropoietic","volume":"305","author":"Leist","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2013.12.023_bib20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00125-010-1727-7","article-title":"Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina","volume":"53","author":"Wang","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.ajpath.2013.12.023_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2119\/2007-00032.Guneli","article-title":"Erythropoietin protects the intestine against ischemia\/reperfusion injury in rats","volume":"13","author":"Guneli","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.ajpath.2013.12.023_bib22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ydbio.2004.08.025","article-title":"The role of erythropoietin in regulating angiogenesis","volume":"276","author":"Kertesz","year":"2004","journal-title":"Dev Biol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.RES.0000260179.43672.fe","article-title":"Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice","volume":"100","author":"Nakano","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.12.023_bib24","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2012.04835.x","article-title":"Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential","volume":"10","author":"Bennis","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajpath.2013.12.023_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","article-title":"Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy","volume":"353","author":"Watanabe","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2013.12.023_bib26","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.0800454105","article-title":"Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications","volume":"105","author":"Tong","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.12.023_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","article-title":"Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model","volume":"12","author":"Suk","year":"2008","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajpath.2013.12.023_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaapos.2005.09.005","article-title":"Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity","volume":"10","author":"Brown","year":"2006","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajpath.2013.12.023_bib29","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.12.023_bib30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1167\/iovs.08-2521","article-title":"Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/emboj\/cdg117","article-title":"HLF\/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin","volume":"22","author":"Morita","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.ajpath.2013.12.023_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ajpath.2011.11.031","article-title":"VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression","volume":"180","author":"Wang","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib33","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","article-title":"A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants","volume":"132","author":"Ohls","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajpath.2013.12.023_bib34","first-page":"576","article-title":"Variable oxygen exposure causes preretinal neovascularisation in the newborn rat","volume":"34","author":"Penn","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2009.06.011","article-title":"Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP","volume":"89","author":"Budd","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajpath.2013.12.023_bib36","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ajpath.2013.05.011","article-title":"Short hairpin RNA-mediated knockdown of VEGFA in M\u00fcller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity","volume":"183","author":"Wang","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib37","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/archophthalmol.2010.158","article-title":"Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity","volume":"128","author":"Budd","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archophthalmol.2010.65","article-title":"Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity","volume":"128","author":"Budd","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib39","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1167\/iovs.07-1356","article-title":"Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model","volume":"49","author":"Saito","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib40","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-05-2519","article-title":"Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway","volume":"66","author":"Carroll","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2013.12.023_bib41","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1182\/blood-2010-07-298083","article-title":"Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC","volume":"117","author":"Frede","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.12.023_bib42","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1600-0854.2006.00462.x","article-title":"Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells","volume":"7","author":"Ewan","year":"2006","journal-title":"Traffic"},{"key":"10.1016\/j.ajpath.2013.12.023_bib43","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1167\/iovs.08-3256","article-title":"The role of supplemental oxygen and JAK\/STAT signaling in intravitreous neovascularization in a ROP rat model","volume":"50","author":"Byfield","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib44","first-page":"1925","article-title":"Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP","volume":"41","author":"Berkowitz","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib45","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"9","author":"Ohlsson","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajpath.2013.12.023_bib46","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/bjc.2012.42","article-title":"Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer","volume":"106","author":"Aapro","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajpath.2013.12.023_bib47","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1073\/pnas.152321399","article-title":"Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury","volume":"99","author":"Junk","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.12.023_bib48","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.ki.5001546","article-title":"Discovering erythropoietin\u2019s extra-hematopoietic functions: biology and clinical promise","volume":"70","author":"Brines","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajpath.2013.12.023_bib49","doi-asserted-by":"crossref","first-page":"19898","DOI":"10.1073\/pnas.0805817105","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy","volume":"105","author":"Sears","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajpath.2013.12.023_bib50","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1167\/iovs.13-12171","article-title":"Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50\/10 model","volume":"54","author":"Trichonas","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajpath.2013.12.023_bib51","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archopht.120.5.595","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1\/2) years in premature infants with birth weights less than 1251 g","volume":"120","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib52","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0031-3955(16)36370-2","article-title":"Retinopathy of prematurity","volume":"34","author":"Flynn","year":"1987","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ajpath.2013.12.023_bib53","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2353\/ajpath.2009.080592","article-title":"RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells","volume":"174","author":"Paragh","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2013.12.023_bib54","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1172\/JCI118334","article-title":"Endothelial cell expression of vasconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide","volume":"96","author":"Morita","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.12.023_bib55","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/CIRCULATIONAHA.105.583732","article-title":"Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice","volume":"113","author":"Satoh","year":"2006","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.ajpath.2015.01.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000}}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:33:34Z","timestamp":1617233614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0002944014000285"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.023","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ajpath.2015.01.004","asserted-by":"object"}]},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}